Sarah Sanghavi's Avatar

Sarah Sanghavi

@sarahsanghavi.bsky.social

Intensivist, Nephrologist @uwnephrology.bsky.social | Via UT Austin, UTSW, WashU, and Mt. Sinai | Views mine https://nephrology.uw.edu/people/faculty/sanghavi-s #nephsky #medsky

1,274 Followers  |  514 Following  |  156 Posts  |  Joined: 09.11.2024  |  2.0078

Latest posts by sarahsanghavi.bsky.social on Bluesky

Dr. Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, echoed that sentiment. “I declined because A.C.I.P. seems to have shifted its mission away from science and evidence-based medicine,” he said in a message, referring to the vaccine committee. “I’m always happy to discuss the science of vaccines with individuals or groups who are committed to truth and genuine intellectual inquiry.”

A majority of the public may be inclined to agree. If the C.D.C. and the American Medical Association were to offer conflicting advice, according to a survey released on Monday by the Annenberg Public Policy Center of the University of Pennsylvania, more than twice as many Americans would trust the medical organization over the nation’s premier public health agency.

Dr. Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, echoed that sentiment. “I declined because A.C.I.P. seems to have shifted its mission away from science and evidence-based medicine,” he said in a message, referring to the vaccine committee. “I’m always happy to discuss the science of vaccines with individuals or groups who are committed to truth and genuine intellectual inquiry.” A majority of the public may be inclined to agree. If the C.D.C. and the American Medical Association were to offer conflicting advice, according to a survey released on Monday by the Annenberg Public Policy Center of the University of Pennsylvania, more than twice as many Americans would trust the medical organization over the nation’s premier public health agency.

Thank you for this reporting @apoorvanyt.bsky.social

www.nytimes.com/2025/12/05/h...

05.12.2025 22:29 — 👍 7    🔁 3    💬 0    📌 0
Post image

What do you want to see at #KidneyWk 2026? Now’s the time to shape it.

Submit your session and faculty suggestions for next year’s program in Denver by Monday, December 15.

Don’t wait—add your ideas before the call closes. 👉 http://asn.kdny.info/WjFe50XBix7

04.12.2025 18:00 — 👍 1    🔁 2    💬 0    📌 0
Preview
Higher blood flow rates in anticoagulation free CRRT improve circuit survival and clinical outcomes AbstractObjective. Anticoagulation-free continuous renal replacement therapy (CRRT) is an essential modality for managing patients with a high bleeding ris

I should mention that this study came out after that presentation, but I still think changes in blood flow rate are likely inconsequential for clotting. academic.oup.com/ckj/advance-...

05.12.2025 02:36 — 👍 1    🔁 0    💬 0    📌 0

It was really interesting researching this topic. Hope it’s useful.

05.12.2025 01:31 — 👍 5    🔁 2    💬 1    📌 0
Fellowship

Are you a peds resident who didn't match into fellowship yesterday, or someone wishes to do peds nephrology, we have a wonderful program waiting for you med.stanford.edu/pednephrolog...
Come work & learn w/us in ☀️ Bay Area!
Reach out to any of us
@xgaeta.bsky.social @4kidney.bsky.social #NephSky

05.12.2025 00:53 — 👍 6    🔁 3    💬 2    📌 1

If you are a resident who didn’t match today, a hospitalist looking for change, or anyone looking to join an amazing and innovative fellowship program in an unbeatable location we have a Nephrology spot open for you!

Contact us if you are interested!

ohsu.edu/school-of-medi…

03.12.2025 18:35 — 👍 1    🔁 3    💬 0    📌 0
Post image

What a Match! We are thrilled to welcome this exceptional group of doctors to our UW Nephrology Fellowship Program!! @uwnephrology.bsky.social @uwmedicine.bsky.social #Seattle #Match2026 #nephsky

03.12.2025 18:03 — 👍 5    🔁 2    💬 0    📌 0

All ELISAs that use biotin strepavidin at risk for this. Which are pretty much all ELISAs

02.12.2025 00:24 — 👍 1    🔁 1    💬 0    📌 0

Biotin was recommended for one of my kidney transplant patients for hair loss associated with tacrolimus. Oral doses may interfere with PTH assays.

02.12.2025 00:05 — 👍 5    🔁 3    💬 4    📌 0
Post image Post image Post image

We had a great turnout for #Cranksgiving, biking food from local grocers to area food banks. Several folks donated funds directly. Everyone had a wonderful time! Over 6,500 lbs of food donated!! Happy Thanksgiving!! 🦃😀🚴‍♂️
@uwnephrology.bsky.social
@uwdeptmedicine.bsky.social
@uwmedicine.bsky.social

26.11.2025 21:17 — 👍 5    🔁 3    💬 0    📌 1
Sandeep Mallipattu, MD - Treating FSGS: Something Old, Something New, Something Still in Motion
YouTube video by University of Washington Division of Nephrology Sandeep Mallipattu, MD - Treating FSGS: Something Old, Something New, Something Still in Motion

It was an honor for us to host Dr. Sandeep Mallipattu in #Seattle for Nephrology Grand Rounds! Take a look at his fantastic talk, "Treating FSGS: Something Old, Something New, Something Still in Motion." #kidney #nephrology #FSGS @uwmedicine.bsky.social #nephsky #meded

youtu.be/Nu8VZHuVTdY

24.11.2025 23:22 — 👍 1    🔁 1    💬 0    📌 0

Agree 💯

23.11.2025 02:42 — 👍 1    🔁 0    💬 0    📌 0

Agree, much prefer the bit of inotropy and precapillary pulmonary vasoconstriction from NE.
journals.lww.com/cjasn/fullte...

23.11.2025 02:26 — 👍 2    🔁 0    💬 1    📌 0

Very odd. The rationale doesn’t reference any sources about titration rate either.

22.11.2025 21:24 — 👍 2    🔁 0    💬 0    📌 0
Post image

1/n Recently attended an international congress about Urinalysis in Santiago, Chile 🇨🇱. I was expecting a small meeting. I was wrong. Pleasantly surprised with the size of the meeting and the energy and interest from the participants. Let me share the highlights of my experience:

21.11.2025 17:23 — 👍 17    🔁 8    💬 2    📌 0
Dr. Karen de Wolski

Dr. Karen de Wolski

Congrats to Dr. Karen de Wolski, selected for the 2026 @asnkidney.bsky.social FIND Pgrm! FIND - Fostering Innovative Leaders in #Nephrology & #Dialysis empowers future generations of neph pros to drive innovation, advance clinical care, and champion positive policy change. 👏👏👏@uwmedicine.bsky.social

21.11.2025 01:00 — 👍 3    🔁 1    💬 0    📌 0
Preview
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias | NEJM Hypokalemia and even low-normal plasma potassium levels increase the risk of ventricular arrhythmias among patients with cardiovascular disease. An assessment of a strategy of actively increasing p...

Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias | New England Journal of Medicine www.nejm.org/doi/full/10....

19.11.2025 23:13 — 👍 2    🔁 0    💬 0    📌 0
Preview
Transforming Cancer Drug Access: Insights Into Utilization and Clinician Satisfaction in a Statewide Cancer Drug Repository Network | JCO Oncology Practice PURPOSEThe rise in high-cost cancer therapies has intensified financial strain on patients with cancer, whereas medication waste simultaneously continues to increase. This study evaluated outcomes…

I often hear "I wish we didn't have to waste these expensive meds every time a patient stops & has extra left over."

Here's what the state of Michigan did to combat this:
- Statewide cancer drug repository, 105 sites
- $26 million value/>100K pills donated to >1K pts

ascopubs.org/doi/10.1200/...

18.11.2025 02:04 — 👍 6    🔁 3    💬 0    📌 0

And beautiful slides as always.

09.11.2025 03:07 — 👍 2    🔁 0    💬 0    📌 0
Post image Post image

Fun in the Houston airport! @uwnephrology.bsky.social #kidneywk

09.11.2025 03:04 — 👍 6    🔁 1    💬 0    📌 0
Post image

Ian McCoy describing higher rates of intradialytic hypotension with more frequent HD in AKI-D including the fresh off the press LIBERATE-D. #kidneywk

08.11.2025 17:13 — 👍 2    🔁 1    💬 0    📌 0

Dr. Babroudi quantifying the problem-it affects about 10,000 patients per year in the US. #kidneywk

08.11.2025 16:45 — 👍 1    🔁 0    💬 0    📌 0
Preview
A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury This trial examines whether a conservative dialysis strategy can improve recovery of kidney function for patients with acute kidney injury who require dialysis.

A much needed study evaluating an intervention for renal recovery in people with AKI requiring dialysis. jamanetwork.com/journals/jam... #kidneywk

08.11.2025 00:46 — 👍 3    🔁 1    💬 0    📌 1
Preview
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria This meta-analysis examines whether estimated glomerular filtration rate or degree of albuminuria, as measured by urinary albumin to creatinine ratio, modifies the effects of sodium-glucose cotranspor...

After empa-kidney, it still wasn’t clear what to do for patients with CKD without diabetes or albuminuria. This meta-analysis suggests you use flozins. #kidneywk

jamanetwork.com/journals/jam...

08.11.2025 00:31 — 👍 11    🔁 5    💬 1    📌 0
Post image

The 4 pillars of CKD management:
RAASi
SGLT2i
MRA
GLP-1 agonists
#KidneyWk
Dr Perkovic calls for combination therapy, but need properly run trials.

06.11.2025 14:39 — 👍 5    🔁 5    💬 0    📌 0
Cover of The Lancet's Nov 8, 2025 issue. Quote on cover reads "The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some mechanisms for benefit beyond adiposity reduction."

Cover of The Lancet's Nov 8, 2025 issue. Quote on cover reads "The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some mechanisms for benefit beyond adiposity reduction."

On the cover, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they don’t have diabetes. 🫀

Read this & more in our new issue: tinyurl.com/58p97aud

07.11.2025 11:31 — 👍 14    🔁 7    💬 1    📌 0

Excellent discussion by @lizkiernanmd.bsky.social on the use of subphenotypes in sepsis-associated AKI for trial enrollment and prognostication. #kidneywk

06.11.2025 23:25 — 👍 1    🔁 0    💬 0    📌 0
Post image Post image

Subphenotyping can change answers. In CLOVERS: SP2 (“leaky endothelium”) had lower mortality with early vasopressors (restrictive fluids), while SP1 favored fluids. EUPHRATES/TIGRIS: endotoxin 0.6–0.9 subgroup signaled benefit → smarter, targeted trials. #KidneyWk #Sepsis #AKI

06.11.2025 23:21 — 👍 4    🔁 1    💬 0    📌 1
Post image

The Eknoyan Lectureship at #KidneyWk will cover KDIGO Guidelines for CKD on Saturday. Read about the speaker in #ASNKidneyNews kidney.pub/KN1710-55

06.11.2025 21:00 — 👍 4    🔁 3    💬 0    📌 0
Post image Post image 06.11.2025 17:00 — 👍 1    🔁 1    💬 0    📌 0

@sarahsanghavi is following 19 prominent accounts